Labs / Assays & in vitro testing

Axcelead
Kanagawa, Japan · axcelead-us.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Axcelead Drug Discovery Partners, Inc. provides drug discovery and development services for biotechnology and pharmaceutical partners. It was formed in 2017 as a Takeda spin-out and is based in Fujisawa, Kanagawa, Japan. Its work spans preclinical discovery programs in small molecules, cell therapy, and immune-oncology.
Their website has a general contact form; we send your quote request through it.
What they offer
Integrated Drug Discovery
Supports drug discovery programs across target identification through candidate selection and IND enabling work.
Axcelead Booster
Provides an integrated drug discovery platform for partner programs.
Target Identification / Validation
Supports identification of novel drug targets using human data-driven transcriptomics and proteomics, and validates targets in human samples and animal disease models.
Hit Identification / Characterization
Designs HTS strategies from assay development through hit characterization using curated library sets and prior HTS experience.
Lead Generation / Optimization
Supports lead generation and optimization within its drug discovery platform.
Candidate Selection
Advances programs toward candidate selection in the discovery workflow.
IND Enabling
Supports preclinical activities needed to advance candidates toward human clinical trials.
Omics
Uses omics technologies to link genes, proteins, and metabolites for biological insight.
Bioinformatics
Converts omics and genomics data into actionable insights for drug discovery.
Targeted Protein Degradation
Provides TPD drug discovery capabilities at the preclinical stage.
RNA-Targeted Small Molecules
Provides integrated RNA-targeted small molecule drug discovery capabilities at the preclinical stage.
In Vitro/In Vivo Pharmacology
Offers pharmacology support as part of its technology platform.
Chemistry
Provides chemistry support within the drug discovery platform.
Genetically Modified Animal
Uses genetically modified animal models as a technology platform.
What they work on
- Modalities
- Small molecule, Peptide, Oligonucleotide, Cell therapy
- Species and models
- human samples, animal disease models, genetically modified animal
- Assays and studies
- transcriptomics, proteomics, high-throughput screening, assay development, hit characterization
- Scale and capacity
- 1.5 million compounds, 700+ HTS experiences, About 240 employees
- Therapeutic areas
- Oncology, Immunology, Neuroscience, Cardiovascular / Metabolic Disease
- Sites
- Fujisawa, Kanagawa, Japan
- Team
- About 240
- Serves
- Japan, around the world
- Founded
- 2017
Similar labs. Aurigene Pharmaceutical Services, MedChem Partners, Sai Life, CDI Labs
Found in a contract services directory. Listing built from axcelead-us.com. Work here? Claim this listing.